Synovics Pharmaceuticals, Inc. Stock

Stocks

SYVC

US87163M1018

Pharmaceuticals

OTC Markets Traded
Market Closed - 11:31:20 09/06/26 pm AEST 5-day change 1st Jan Change
0.000100 USD +9,900.00% Intraday chart for Synovics Pharmaceuticals, Inc. -.--% -
6 months+9,900.00%

Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.47M 1.35M 1.22M 2.29M 156M 2.33M 16.12M 6.47M 81.94M 6.16M 6.03M 258M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.28M 6.7M 6.07M 11.34M 772M 11.55M 79.86M 32.06M 406M 30.51M 29.86M 1.28B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
1 day+9,900.00%
6 months+9,900.00%
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0
5 years 0
Extreme 1.0E-6
0
10 years 0
Extreme 1.0E-6
0
Change 5-day change 1-year change 3-year change Capi.($)
+9,900.00%-.--%-.--%-.--% 3.65K
+3.19%+11.31%+64.28%+155.66% 1,263B
-0.73%+3.56%+44.65%+83.74% 658B
+1.41%+3.24%+35.25%+106.98% 521B
+0.42%+3.20%+55.81%+69.71% 391B
+2.18%+2.93%+73.90%+45.38% 369B
+1.12%+4.52%+34.76%+57.00% 307B
+6.96%+8.86%+11.95%+35.06% 290B
+1.15%+6.09%+56.15%+78.66% 252B
+3.06%+9.38%+42.48%+112.84% 212B
Average +991.88%+5.31%+41.92%+74.50% 426.19B
Weighted average by Cap. +2.01%+6.60%+50.51%+99.19%

Financials

2007 2008
Net sales 23.47M 21.02M 19.33M 17.52M 32.74M 2.23B 33.36M 231M 92.54M 1.17B 88.07M 86.19M 3.7B 25.96M 23.25M 21.39M 19.38M 36.22M 2.46B 36.9M 255M 102M 1.3B 97.42M 95.35M 4.09B
Net income -20.86M -18.68M -17.18M -15.57M -29.1M -1.98B -29.65M -205M -82.26M -1.04B -78.28M -76.61M -3.29B -4.01M -3.59M -3.3M -2.99M -5.59M -380M -5.69M -39.35M -15.8M -200M -15.03M -14.71M -631M
Net Debt 18.79M 16.83M 15.48M 14.03M 26.22M 1.78B 26.71M 185M 74.1M 938M 70.52M 69.02M 2.96B 6.49M 5.81M 5.35M 4.84M 9.05M 616M 9.22M 63.74M 25.59M 324M 24.35M 23.83M 1.02B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
155
  1. Stock Market
  2. Stocks
  3. SYVC Stock